Skip to main content
. 2019 Nov 3;2019:1512326. doi: 10.1155/2019/1512326

Figure 7.

Figure 7

miR-200a could not provide cardiac protection against DOX-induced acute cardiotoxicity in Nrf2-deficient mice: (a) schedule of Nrf2 deficiency in mice with the acute DOX treatment; (b) the level of Nrf2 in the hearts (n = 6); (c) EF (n = 8); (d, e) the levels of NT-proBNP and MDA in the hearts (n = 6); (f) caspase 3 activity (n = 6). P < 0.05.